Comparative Assessment of Angiotensin Receptor Blockers in Different Clinical Settings

Vascular Health and Risk Management
doi 10.2147/vhrm.s7263
Full Text
Abstract

Available in full text

Date
Authors

Unknown

Publisher

Informa UK Limited

Related search

Angiotensin Receptor Blockers (ARBs)

CMAJ
Medicine
2011English

Comparative Analysis of the Anticancer Activity of Angiotensin Receptor Blockers - Irbesartan and Telmisartan

Asian Journal of Pharmaceutical and Clinical Research
PharmacologyPharmaceutical Science
2018English

Angiotensin-Converting Enzyme Inhibitors Versus Angiotensin Receptor Blockers

JRAAS - Journal of the Renin-Angiotensin-Aldosterone System
Internal MedicineEndocrinology
2006English

Combining Angiotensin-Receptor Blockers With Angiotensin-Converting-Enzyme Inhibitors

CMAJ
Medicine
2011English

The Effect of Angiotensin II Receptor Blockers on Hyperuricemia

Therapeutic Advances in Chronic Disease
Medicine
2015English

Are the Eutrophic Effects of Angiotensin Receptor Blockers Real?

Hypertension
Internal Medicine
2006English

Comparison of Angiotensin Receptor Blockers and Angiotensin Converting Enzyme Inhibitors for Glycaemic Regulation

Endocrine Abstracts
2014English

Angiotensin Receptor Blockers as Tentative SARS‐CoV‐2 Therapeutics

Drug Development Research
Drug Discovery
2020English

The Comparative Efficacy and Safety of the Angiotensin Receptor Blockers in the Management of Hypertension and Other Cardiovascular Diseases

Drug Safety
ToxicologyPharmacology
2014English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy